TriDerma Recalls Pain Relief Cream for Child-Resistant Packaging Failure
TriDerma is recalling Pain Relief Cream with Lidocaine because the packaging fails to meet child-resistant closure requirements, posing a poisoning risk to young children.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (poisoning via lidocaine ingestion) where injury has not yet been reported, which aligns with the 'High' severity criteria in the rubric.
Plain-English summary
TriDerma, of Corona, Calif., is recalling approximately 410 units of Pain Relief Cream with 4% Lidocaine. The recall involves the product in a 4-ounce jar and a 2.2-ounce tube. The affected products were sold online at www.triderma.com from January 2018 through April 2019 for approximately $22 for the jar and $15 for the tube.
The recall is due to the packaging's failure to meet the child-resistant closure requirements of the Poison Prevention Packaging Act. Because the cream contains lidocaine, it poses a risk of poisoning to young children if they apply it to their skin or ingest it. No injuries have been reported.
Consumers should immediately store the topical anesthetic in a safe location out of reach of children. They should contact TriDerma at 800-279-7282, email [email protected], or visit www.triderma.com to request a free replacement child-resistant cap. TriDerma is also contacting all known purchasers directly.
The recalled product
- Product
- Pain Relief Cream with Lidocaine
- Manufacturer
- TriDerma, of Corona, Calif.
- Hazard
- Affected units
- 410
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · poisoning
See all →- HighMedPride baby oil lacks the required child-resistant packaging
CPSC · 2026-06-25
- High
- High
- High
- High